Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global gynaecology drugs market size was valued at USD 28.54 billion in 2023, driven by the rise in the geriatric population across the globe. The market size is anticipated to grow at a CAGR of 6.1% during the forecast period of 2024-2032 to achieve a value of USD 48.63 billion by 2032.
The medications that are used by women when they are pregnant are called as gynaecology drugs. The most used gynaecology drugs are analgesics, antimetics, antacids, antimicrobials, antiemetics, antacids, antihistamines, antimicrobials, diuretics, hypnotics, and tranquilizers, among others. These drugs are used to treat certain disorders that occur during pregnancy. The gynaecology drugs are used in the treatment of medical issues with female reproductive system and during pregnancy and childbirth. Hormonal and non-hormonal therapies are the major kind of treatments that are provided in gynaecology drugs. Hormonal therapy is also one of those as it blocks, reduces, or adds hormones that stop the growth of the cancer cells which require the growth of hormones.
The increasing investments by the key players of the market in the development and research procedures to develop personalized cancer vaccines, including gynaecology cancers, is one of the key factors which is contributing to the gynaecology drugs market growth. Some of them have even reached the trial phases before their final launch in the market. Increased use of genetic sequencing and precision medicine has been going on to develop new drug therapies and cancer treatments to decrease the rate of Gynaecology cancer.
Market Breakup by Therapy Type
Market Breakup by Indication
Market by Route of Administration
Market Breakup by Distribution Channel
Market Breakup by End User
Market Breakup by Region
The increasing number of women suffering from ovarian cancer is expected to favour the gynaecology drugs market expansion. The gynaecology drug market has been growing and is expected to grow in the coming years as well. Due to the increasing incidence of gynaecology cancer, the market is poised to witness robust growth in the coming years.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Therapy Type |
|
Breakup by Indication |
|
Breakup by Route of Administration |
|
Breakup by Distribution Channel |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market for gynaecology drugs attained a value of about USD 28.54 billion in 2023, driven by the rising cases of ovarian cancer.
The gynaecology drugs market size is anticipated to grow at a CAGR of 6.1% during the forecast period of 2024-2032 and reach a market value of USD 48.63 million by 2032.
The rising healthcare sector and theincreasing incidence of ovarian cancer are the key drivers aiding the growth of the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The different types of products in the market include hormonal therapy and non-hormonal therapy.
The different indications in gynaecology drugs include gynaecology cancers, endometriosis, female infertility, menopausal disorder, gynaecology infections, polycystic ovary syndrome (PCOS), and contraception, among other indications.
The different routes of administration include oral, parenteral, and intravaginal, among others.
The end users in the market include hospitals, specialty clinics, diagnostic centers, research institute, and home healthcare, among others.
The different types of distribution channels include hospital pharmacy, retail pharmacy, and online pharmacies, among others.
The increasing investments in the development and research procedures to develop personalized cancer vaccines in the market is a major trend in the market.
Key players involved in the market are Pfizer, Inc., Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Bayer AG Financial Analysis, AbbVie Inc., Lupin Pharmaceuticals Inc., Therapeutics MD Inc., Ferring Holding S.A., Teva Pharmaceutical Industries Limited, Addex Therapeutics Ltd., Allergan Plc., and Eli Lilly and Company.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share